However, in 2019, Xing et al. analyzed the role of the aforementioned lncRNA in hypoxia-induced PAH (HPH) and discovered that MEG3 levels were substantially elevated in PASMCs. The gene discussed is MEG3; the disease is pulmonary arterial hypertension.